DK200189A - Hiv-env-kodet peptid, der kan udvaelge hiv-inhiberende antistoffer hos pattedyr - Google Patents

Hiv-env-kodet peptid, der kan udvaelge hiv-inhiberende antistoffer hos pattedyr Download PDF

Info

Publication number
DK200189A
DK200189A DK200189A DK200189A DK200189A DK 200189 A DK200189 A DK 200189A DK 200189 A DK200189 A DK 200189A DK 200189 A DK200189 A DK 200189A DK 200189 A DK200189 A DK 200189A
Authority
DK
Denmark
Prior art keywords
peptid
mammals
encoded
hiv env
animal antibody
Prior art date
Application number
DK200189A
Other languages
English (en)
Other versions
DK200189D0 (da
Inventor
William Robert Kenealy
Stephen Robert Petteway
Paul John Durda
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/324,027 external-priority patent/US5562905A/en
Application filed by Du Pont filed Critical Du Pont
Publication of DK200189D0 publication Critical patent/DK200189D0/da
Publication of DK200189A publication Critical patent/DK200189A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK200189A 1988-04-26 1989-04-25 Hiv-env-kodet peptid, der kan udvaelge hiv-inhiberende antistoffer hos pattedyr DK200189A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18633388A 1988-04-26 1988-04-26
US07/324,027 US5562905A (en) 1988-04-26 1989-03-20 Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals

Publications (2)

Publication Number Publication Date
DK200189D0 DK200189D0 (da) 1989-04-25
DK200189A true DK200189A (da) 1989-10-27

Family

ID=26881983

Family Applications (1)

Application Number Title Priority Date Filing Date
DK200189A DK200189A (da) 1988-04-26 1989-04-25 Hiv-env-kodet peptid, der kan udvaelge hiv-inhiberende antistoffer hos pattedyr

Country Status (10)

Country Link
EP (1) EP0339504A3 (da)
JP (1) JPH02160800A (da)
AU (1) AU632475B2 (da)
DK (1) DK200189A (da)
FI (1) FI891957A7 (da)
HU (1) HUT51296A (da)
IL (1) IL90058A0 (da)
NO (1) NO891711L (da)
NZ (1) NZ228869A (da)
PT (1) PT90376B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097759T3 (es) * 1989-04-25 1997-04-16 Tanox Biosystems Inc Anticuerpos especificos para el dominio de fijacion de cd4 de hiv.
AU6036690A (en) * 1989-06-05 1991-01-07 Helen F. Carson Human monoclonal antibodies to hiv-1mn gp 120
SE9000333D0 (sv) * 1990-01-31 1990-01-31 Britta Wahren Monoklonal antikropp
US7041293B1 (en) 1990-04-03 2006-05-09 Genentech, Inc. HIV env antibodies
EP0527760B1 (en) * 1990-04-03 1995-07-19 Genentech, Inc. Methods and compositions for vaccination against hiv
AU8007991A (en) * 1990-06-29 1992-01-23 Daniel Zagury Methods of inducing immune response to aids virus
US5712373A (en) * 1990-07-02 1998-01-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute HIV monoclonal antibody specific for the HTLV-IIImn gp120 envelope glycoprotein
JP2989862B2 (ja) * 1990-07-02 1999-12-13 財団法人化学及血清療法研究所 モノクローナル抗体
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
IL98845A0 (en) * 1990-07-19 1992-07-15 Merck & Co Inc Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties,their preparation and pharmaceutical compositions containing them
IL99077A0 (en) * 1990-08-13 1992-07-15 Merck & Co Inc New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them
US5346989A (en) * 1990-08-22 1994-09-13 Syntello Vaccine Development Kb Peptides for use in induction of T cell activation against HIV-1
US5627035A (en) * 1990-08-22 1997-05-06 Syntello Vaccine Development Ab Peptides that block human immunodeficiency virus and methods of use thereof
EP0594638A1 (en) * 1991-06-03 1994-05-04 Syntello Vaccine Development Ab Peptides for use in induction of t cell activation against hiv-1
EP0554446B1 (en) * 1991-08-22 1998-11-04 Nissin Shokuhin Kabushiki Kaisha Monoclonal antibodies useful in therapy of HIV-1 infection
WO1994004574A1 (en) * 1991-08-22 1994-03-03 Nissin Shokuhin Kabushiki Kaisha Hiv immunotherapeutics
ES2145768T3 (es) * 1991-12-02 2000-07-16 Univ Texas Composiciones para provocar respuestas de linfocitos t citotoxicos contra virus.
IL103928A0 (en) * 1991-12-11 1993-04-04 American Home Prod Expression of specific immunogens using viral antigens
JPH0748276A (ja) * 1992-03-26 1995-02-21 Inmeru:Kk Ｈｉｖ感染症予防ワクチンおよびその製造法
WO1993019775A1 (en) * 1992-03-31 1993-10-14 Medimmune, Inc. Administration of liposomes containing peptides or proteins including ctl eptitopes of hiv proteins
WO1994008618A1 (en) * 1992-10-13 1994-04-28 Children's Hospital Oral tolerance and immune suppression in the treatment of aids
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
ES2213148T3 (es) * 1993-03-11 2004-08-16 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Anticuerpo monoclonal dirigido contra el vih.
US6180134B1 (en) 1993-03-23 2001-01-30 Sequus Pharmaceuticals, Inc. Enhanced ciruclation effector composition and method
AU700371B2 (en) * 1993-06-07 1999-01-07 Genentech Inc. Hiv envelope polypeptides
WO1995010777A1 (en) * 1993-10-15 1995-04-20 Rakowicz Szulczynska Ewa M Detection and treatment of breast and gynecological cancer
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
ZA975889B (en) * 1996-07-08 1998-02-23 Genentech Inc HIV envelope polypeptides and vaccine.
FR2874612A1 (fr) * 2004-08-27 2006-03-03 Commissariat Energie Atomique Epitotes t cd4+ du vih restreints a hla-dp4 et leurs applications
EP2778681A1 (en) * 2013-03-15 2014-09-17 Biomay Ag Method for diagnosing a viral infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2571968B1 (fr) * 1984-10-18 1989-03-17 Pasteur Institut Virus purifie des lymphadenopathies et du syndrome d'immuno-depression acquise et antigenes d'enveloppe de ce virus, procede d'obtention de ce virus et de ces antigenes d'enveloppe de ce virus, applications de ce virus ou de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic des susdites affections.
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
DE3587512T2 (de) * 1984-10-18 1993-12-02 Centre Nat Rech Scient Hüllenantigene vom menschlichen Immunodefizienz-Virus und deren Verwendungen.
EP0245362B1 (en) * 1985-10-24 1994-06-29 Ronald C. Kennedy Synthetic peptides and use for diagnosis and vaccination for aids and arc
WO1987007616A1 (en) * 1986-06-12 1987-12-17 Biogen N.V. Peptides involved in the pathogenesis of hiv infection
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
DE3853779T2 (de) * 1987-05-29 1995-09-07 Baylor College Medicine Hiv-1 neutralisierende monoklonale antikörper.
EP0400076B1 (en) * 1988-01-26 1996-05-15 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce A synthetic antigen evoking anti-hiv response

Also Published As

Publication number Publication date
EP0339504A3 (en) 1990-09-12
AU632475B2 (en) 1993-01-07
IL90058A0 (en) 1989-12-15
DK200189D0 (da) 1989-04-25
PT90376B (pt) 1995-01-31
NO891711L (no) 1989-10-27
PT90376A (pt) 1989-11-10
EP0339504A2 (en) 1989-11-02
FI891957L (fi) 1989-10-27
NO891711D0 (no) 1989-04-25
AU3332089A (en) 1989-11-02
HUT51296A (en) 1990-04-28
FI891957A0 (fi) 1989-04-25
NZ228869A (en) 1992-02-25
FI891957A7 (fi) 1989-10-27
JPH02160800A (ja) 1990-06-20

Similar Documents

Publication Publication Date Title
DK200189A (da) Hiv-env-kodet peptid, der kan udvaelge hiv-inhiberende antistoffer hos pattedyr
FI892135L (fi) Rekombinant antikropp.
DE69021002D1 (de) Schimärische Hepadnavirus-Kernantigenproteine.
DK666389A (da) Monoklonalt antistof
DE68914244D1 (de) Monoklonaler Antikörper.
FI884013A7 (fi) Sytokiinien konjugaatit immunoglobuliinien kanssa.
FI925631L (fi) Monoklonala antikroppar
FI882173A7 (fi) Synteettinen peptidiantigeeni HIV-2-tartunnan toteamiseksi.
DE3879452D1 (de) Chimaere antikoerper.
DE3854502D1 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
NO881151D0 (no) Syntetisk hiv-1-antigen.
DE3885355D1 (de) Monoklonale Antikörper.
DK63187D0 (da) Krydsbeskyttende monoklonale antistofpraeparater
NO890774D0 (no) Ekspresjon av hiv-bindende proteiner.
NO177311C (no) Anti-fucosylceramid monoklonalt antistoff
FI893545L (fi) Maenskans protein c-mutanter och foerfarande foer deras framstaellning.
DE3780256D1 (de) Anti-pci-monoklonaler antikoerper.
DK69690A (da) Humane anti-rh(d) monoklonale antistoffer
DK717888D0 (da) Monoklonale antistoffer
NO890116D0 (no) Monoklonale antistoffer.
FI882741A7 (fi) Rekombinantti-HTLV-III-proteiineja ja niiden käyttötapoja.
DK69590D0 (da) Humane anti-rh(d) monoklonale antistoffer
DE69023717D1 (de) Monoklonaler Antikörper.
DK370089D0 (da) Anti-urokinase monoklonale antistoffer
FI893928A7 (fi) Monoklonala motkroppar.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment